Skip to main content

Advertisement

Table 3 Minimal inhibition concentration (µg/ml) of compound 9

From: A comprehensive review on biological activities of oxazole derivatives

Compd. MIC (µg/ml)
S. aureus E. coli
FDA 209P KMP 9 NIHJ JC-2 W3110 ∆acrA
9 2 2 64 4
Sparfloxacin 0.125 128 0.032 0.004
Novobiocin 0.25 0.25 64 0.5